Local Treatments of Oligometastatic and Oligoprogressive NSCLC Should Become the Standard of Care. Videtic GMM. J Thorac Oncol 2023;18:986-989.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Videtic GMM. Local Treatments of Oligometastatic and Oligoprogressive NSCLC Should Become the Standard of Care. J Thorac Oncol 2023;18:986-989.
PMID: 37479329